Comparison of eleven in vitro diagnostic assays for the detection of SARS-CoV-2 RNA.
Ontology highlight
ABSTRACT: Transmission mitigation of SARS-CoV-2 requires the availability of accurate and sensitive detection methods. There are several commercial ad hoc molecular diagnostic kits currently on the market, many of which have been evaluated by different groups. However, in low resource settings the availability and cost of these commercial kits can be a limiting factor for many diagnostic laboratories. In such cases alternatives need to be identified. With this in mind, eight commercial reverse transcription quantitative real-time PCR (RT-qPCR) master mixes from Applied Biosystems (Thermo Fisher Scientific), Bio-Rad, Biotech Rabbit, Promega, Qiagen, QuantaBio, Invitrogen (Thermo Fisher Scientific) and Takara using the same commercial primer and probe mix [LightMix® Modular SARS and Wuhan CoV E-gene m
SUBMITTER: Dundon WG
PROVIDER: S-EPMC8166808 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA